Esperion Therapeutics Inc... (ESPR)
Esperion Therapeutics Max Pain By Strike
ESPR trades at $2.1, 40.0% above the near-term max pain of $1.5 expiring Aug 15, 2025 (0 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($0.5-$6284.9), signaling increased put positioning or downside protection. Key magnetic zone at 1 where 4 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Esperion Therapeutics Max Pain By Expiry
Max pain for ESPR shows a downward trend from 6284.9 to 0.5, indicating bearish sentiment or hedging activity. The 799% spread signals divergent expectations across timeframes. Most levels below 2.1 may cap rallies. Strong magnetic level at 1 (4 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
Expiration Date | Max Pain | Max Pain vs Current Price |
---|---|---|
Aug 15, 2025 | 1.5 | -0.60 (-28.40%) |
Sep 19, 2025 | 1.5 | -0.60 (-28.40%) |
Oct 17, 2025 | 0.5 | -1.60 (-76.13%) |
Dec 19, 2025 | 1 | -1.10 (-52.27%) |
Jan 16, 2026 | 2 | -0.10 (-4.53%) |
Mar 20, 2026 | 1 | -1.10 (-52.27%) |
Jan 15, 2027 | 1 | -1.10 (-52.27%) |
Jan 23, 2064 | 6284.9 | 6282.80 (299895.23%) |